<DOC>
	<DOCNO>NCT00836524</DOCNO>
	<brief_summary>Objective : To investigate role maternal serum YKL-40 uterine artery doppler , gestational age 12 , 20 , 25 32 week , relation preeclampsia intrauterine growth restriction . The serum marker YKL-40 related condition involve inflammation , infection , tissue remodeling , fibrosis cancer . IUGR preeclampsia know related inflammation tissue remodel . Methods : woman attend screen downs syndrome scan uterine artery doppler deliver blood sample GA 12 , 20 , 25 32 respectively . When pregnancy outcome register medical record blood sample retrieve analyzed serum YKL-40 . Serum YKL-40 correlate presence bilateral notching , preeclampsia different degree intrauterine growth restriction .</brief_summary>
	<brief_title>Is Serum YKL-40 Capable Predicting Intrauterine Growth Restriction ( IUGR ) Preeclampsia ?</brief_title>
	<detailed_description />
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>CHI3L1 protein , human</mesh_term>
	<criteria>Pregnant danish speeking woman Conditions/diseases involve chronical inflammation , immunological activity</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>IUGR</keyword>
	<keyword>Preeclampsia</keyword>
	<keyword>ultrasound</keyword>
	<keyword>YKL-40</keyword>
</DOC>